Skip to main content

$0.070 (0.00%)

High

$0.08

Low

$0.07

Trades

14

Turnover

$24,276

Volume

333,655
30 June 2023 at 4:10pm
Register to track BDX and receive email alerts.

BCAL Enters US Product Development Agreement with Precion

StockBot

416,823 posts

BDX released this announcement to the ASX on 28 June 2022, 11:14. The announcement is marked as price sensitive, and is 2 page(s) in length and 50.05kb in size.

You can view all announcements from BDX and see how they appear on a price chart on the announcements page.

At the date of this announcement, BDX was 0.000% short sold according to ASIC data. It was ranked the 638th most shorted stock on the ASX. It is now ranked as the 624th most shorted stock on the ASX with 0.000% of total shares short sold as of the latest reported data (06 June 2025).

Other Recent Announcements from BDX
Notification regarding unquoted securities - BDX 30 June 2023, 8:41
Proposed issue of securities - BDX 30 June 2023, 8:34
BCAL Findings Presented at ASCO Annual Meeting 6 June 2023, 12:14
BCAL Enters US Product Development Agreement with Precion 28 June 2022, 11:14
Change in substantial holding 27 June 2022, 14:49
BCAL Presentation Accepted for 2022 ASCO Annual Meeting 1 June 2022, 8:29
Application for quotation of securities - BDX 3 May 2022, 8:11
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track BDX and receive email alerts.